EUVIMEDEUVIMED entdecken
Crossref

Role of EBUS‐TBNA/EUS‐FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10‐year experience in two tertiary care academic centers

Asghar Naqvi, Michael Bonert, Christian Finley, Katarzyna Czarnecka-Kujawa, Kazuhiro Yasufuku, Joerg Schwock, Vathany Kulasingam, Rohan John, Hyang-Mi Ko iD

Cancer Cytopathology · 2023

DOI: 10.1002/cncy.22751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2023. Verfasst von Asghar Naqvi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Lung Neoplasms, Amyloidosis, Lymphoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objectives of this study were to investigate the utility of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA)/endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) for the diagnosis of amyloidosis coupled with the feasibility of mass spectrometry (MS) for amyloid subtyping.

Methods

All patients who had amyloid diagnosed by EBUS‐TBNA/EUS‐FNA at two tertiary care centers from 2011 to 2020 were retrieved along with the MS subtype, clinical findings, and outcomes.

Results

Eight patients were included: seven underwent EBUS‐TBNA of mediastinal lymph nodes, and one underwent EUS‐FNA of a periportal lymph node. Ages ranged from 37 to 79 years (median, 69 years), with equal numbers of men and women. Presenting clinical history included one case each of follicular lymphoma, lymphoplasmacytic lymphoma, rheumatoid arthritis, possible sarcoid, cirrhosis, and chronic renal insufficiency, and one case each of suspected pulmonary and cardiac amyloidosis. All cases showed waxy, amorphous material on direct smears ( n = 5) or ThinPrep slides ( n = 3), which were confirmed as amyloid on Congo Red staining. Immunohistochemistry showed dominant lambda staining in two of three cases. MS was performed in all cases and identified five of the light‐chain (AL) type, one of the heavy‐chain/AL type, and two suggestive of AL amyloidosis. Bone marrow biopsy performed in seven patients demonstrated that three had monoclonal plasma cells and one had lymphoplasmacytic lymphoma. Two of four patients with systemic amyloidosis received chemotherapy and remained alive, whereas three with localized disease remained stable under observation.

Conclusions

EBUS‐TBNA/EUS‐FNA is effective for amyloidosis diagnosis and provides adequate material for ancillary tests, including MS, which can identify the precursor amyloidogenic protein, leading to appropriate patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAmyloidosisLymphomaMaleHumansFemaleAdultMiddle AgedAgedEndoscopic Ultrasound-Guided Fine Needle AspirationTertiary Care CentersTertiary Health CareBronchoscopyMediastinumLymph NodesNeoplasm Staging

Stichwörter der Autor:innen

amyloidcytologyendobronchial ultrasound-guided transbronchial needle aspirationlymph nodemass spectrometry

Autor:innen und Institutionen

  • Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Thoracic Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Division of Thoracic Surgery, University Health Network, Toronto, Ontario, Canada.
  • Division of Respirology, University Health Network, Toronto, Ontario, Canada.
  • Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Hyang-Mi Ko

Zitieren

APA

Naqvi, A., Bonert, M., Finley, C., Czarnecka-Kujawa, K., Yasufuku, K., Schwock, J., Kulasingam, V., John, R., & Ko, H. M. (2023). Role of EBUS‐TBNA/EUS‐FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10‐year experience in two tertiary care academic centers. Cancer Cytopathology. https://doi.org/10.1002/cncy.22751

Vancouver

Naqvi A, Bonert M, Finley C, Czarnecka-Kujawa K, Yasufuku K, Schwock J, et al. Role of EBUS‐TBNA/EUS‐FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10‐year experience in two tertiary care academic centers. Cancer Cytopathology. 2023. doi:10.1002/cncy.22751

BibTeX
@article{Naqvi2023,
  author = {Naqvi, Asghar and Bonert, Michael and Finley, Christian and Czarnecka-Kujawa, Katarzyna and Yasufuku, Kazuhiro and Schwock, Joerg and Kulasingam, Vathany and John, Rohan and Ko, Hyang-Mi},
  title = {Role of EBUS‐TBNA/EUS‐FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10‐year experience in two tertiary care academic centers},
  journal = {Cancer Cytopathology},
  year = {2023},
  doi = {10.1002/cncy.22751}
}
Kostenlos starten →